Table 2 Prevalence of VTE in Covid-19 patients in different geographical areas
Continent | Add of studies | Prevalence of VTE | p-value | Add of studies | p-value for heterogeneity |
|---|---|---|---|---|---|
Asia | 3 | 0.073 (95% CI = 0.003–0.21) | 0.023 | - | - |
Australia | 1 | 0.03 (95% CI = 0.025–0.04) | 0.000 | - | - |
Europe | 26 | 0.23 (95% CI = 0.15–0.32) | 0.000 | 98.7 | 0.000 |
USA | 8 | 0.093 (95% CI = 0.043–0.16) | 0.000 | 98.9 | 0.000 |
Total | 38 | 0.17 (95% CI = 0.13–0.22) | 0.000 | 98.8 | 0.000 |